Please cite this article as: Pradipta IS, Boveneind-Vrubleuskaya Nv't, Akkerman OW, Alffenaar J-WC, Hak E, Predictors for treatment outcomes among patients with drug-susceptible tuberculosis in the Netherlands: a retrospective cohort study, Clinical Microbiology and Infection (2018), doi: https:// ABSTRACT 66 Objectives: We evaluated treatment outcomes and predictors for poor treatment outcomes 67 for tuberculosis (TB) among native-and foreign-born patients with drug-susceptible TB 68 (DSTB) in the Netherlands. 69
Although tuberculosis (TB) is a global health problem [1] , the associated burden in Europe 92 has been mainly attributed to the travel and migration of people from high-to low-TB burden 93 countries [2] [3] [4] . Several groups, including immigrants, asylum seekers, prisoners and 94 homeless individuals, have been identified as high-risk groups [4, 5] . Hence, adequate 95 treatment management is required, especially for high-risk groups. 96
The Netherlands has a low TB incidence, with an estimated incidence of 5.9/100,000 97 population in 2016 [5] . According to the Netherlands Tuberculosis Registry (NTR), drug-98 susceptible TB (DSTB) is the most common form of TB in the Netherlands. From 2005 to 99 2015, 72% of cases (n/N= 7,416/10,303) were identified as using standard treatment for 100 DSTB. A previous study from the Netherlands (1993 Netherlands ( -1997 identified a higher probability of 101 treatment default among asylum seekers, immigrants and illegal immigrants [6] . However, 102 updated data are needed to determine whether being in a risk group or other factors 103 contribute to poor outcomes of TB treatment and to evaluate the success of current 104 treatment programmes in the Netherlands. We therefore aimed to evaluate treatment 105 outcomes and predictors for poor treatment outcomes for tuberculosis (TB) among native-106 and foreign-born patients with drug-susceptible TB (DSTB) in the Netherlands. hospitals. NTR data collection occurs throughout the TB diagnostic and treatment period, 129 and the information is entered by the physician or nurse into an electronic report via the 130
Online Registration System for Infectious Diseases in Infectious Diseases Surveillance 131
Information System (OSIRIS) after the diagnosis is made. KNCV TB and MPHS check the 132 registrations for completeness and consistency through an interactive process. MPHS 133 receives reminders when records remain incomplete. The online system enables MPHS to 134 correct and add information to patient records. 135
136

Study subjects 137
We included patients with TB aged ≥18 years who were registered in the NTR database and 138 classified as being infected with Mycobacterium tuberculosis strain that was considered fully 139 sensitive to first-line anti-TB drugs and treated during the study period. From this cohort of 140 eligible patients, those with an unknown treatment outcome, i.e. no treatment initiated, 141 treatment ongoing and treatment continued elsewhere with unknown results during a 1-year 142 period, were excluded. 
Potential predictors and definitions 147
Potential predictors for a poor outcome of TB treatment were identified at baseline (before or 148 during diagnosis) to predict the incidence of the study outcome. We selected a set of 149 potential predictors based on previously published articles (see Supplementary 1), input 150 from TB practitioners and information from the NTR database. These potential predictors 151 were classified into five categories: (1) 
Primary outcomes 162
We retrospectively followed patients from the beginning to the end of DSTB treatment for one 163 episode of TB during a 1-year period. According to the WHO criteria [7], we categorised the 164 study outcomes into unsuccessful treatment and TB-associated mortality. Unsuccessful 165 treatment was defined as a combination of defaulted and failed treatment. Treatment default 166 cases met one of the following four conditions: interruption of TB treatment for ≥2 167 consecutive months, incomplete treatment for 6 months within a 9-month treatment period, 168 incomplete treatment for 9 months within a 12-month treatment period and completion of 169 ( Supplementary Table S1 ). 175 176
Statistical analysis 177
Distributions of subjects' characteristics and the cumulative incidences were examined using 178 descriptive statistics. The cumulative incidence of the study outcomes were calculated by 179 dividing incidence of the outcome with the number of DSTB cases during the observation 180 period. We eliminated potential predictors if >10% of the data were missing. We used the chi-181 square test or Fisher's exact test (when expected cell size was <5) for univariate analyses of 182 categorical covariates. Variables with a p-value of <0.25 in the univariate analysis were 183 considered for inclusion in the multivariate analysis. If the number of variables exceeded the 184 assumption of 10 events per variable examined, we considered a stricter univariate p-value 185 (<0.15) for inclusion in the multivariate analysis [10] . To increase the statistical power and 186 validity, we minimised the degree of freedom in the predictor model by combining predictors 187 that measured a similar concept and had similar estimated risks in the univariate analysis 188 [10] . Variables for which there were no incidences of the study outcome in the indicator 189 group were not included in the multivariate analysis. A backward step elimination based on a 190 p-value of >0.05 was used for the multivariate analysis. We used complete case analysis that 191 excluded patients with missing values [10] . Odds ratios (ORs) with 95% confidence intervals 192 (CIs) were calculated to quantify the level of association between variables and outcomes. 193
The calibration of the multivariate analysis model was assessed using the Lemeshow test, while discrimination was estimated using a receiver operating characteristic 195 curve with a 95% CI. We used Statistical Package for the Social Science, version 23 (SPSS; 196 IBM Corp., NY, USA) for Windows™ in all statistical analyses; a final p-value of <0.05 was 197 considered significant in the multivariate analysis. We followed the STROBE guidelines for 198 reporting this study [11] . 199
Baseline characteristics of study subjects 202
Of the 10,303 adult cases with TB registered during the study period, we identified 5,674 203 cases with DSTB who fulfilled the study criteria (Figure 1 ). Most patients with DSTB were 204 foreign-born (71%, n/N = 4,042/5,674; Table 1 ). As described in Figure 1 , 192 patients with 205 DSTB were lost to observation and had missing information about treatment outcomes. 206
Missing information about TB treatment outcomes was significantly more frequent (p < 0.05) 207 among males, foreign-born patients, prisoners, those with pulmonary TB, those with TB 208 diagnosis from outside the Netherlands, immigrants, illegal immigrants and those with a 209 history of travel from/to an endemic area >3 months earlier ( Supplementary Table S2 ). 210 211
Incidence of DSTB 212
We observed a significant declining trend in the number of DSTB cases within the study 213 period (p <0.05), with cumulative incidences of unsuccessful TB treatment and TB-214 associated mortality as 2.6% (146/5,674) and 2.0% (112/5,674), respectively. The highest 215 annual cumulative incidence for both these outcomes was identified in 2011 ( Fig. 2) . 216 217
Predictors for outcomes 218
We combined asylum seekers and immigrants as one covariate in the analysis because 219 similar residential status outside the Netherlands was thought to yield relatively similar 220 statistical associations in the univariate analysis. In the univariate analysis, immigrants and 221 asylum seekers had ORs (95% CI) of 0.90 (0.48-1.67) and 1.57 (0.97-2.54) for unsuccessful 222 treatment outcome, while for mortality outcome had ORs (95% CI) of 0.19 (0.05-0.80) and 223 0.09 (0.12-0.62), respectively. 224
In the univariate analysis, sex, age, homelessness and prisoner status were 
Although most cases in our study involved foreign-born patients, no significant differences in 243 treatment outcomes were observed between native-and foreign-born patients. Immigrants 244 and asylum seekers had a lower risk of death than other patients and no significant 245 prisoners were more likely to be lost to treatment follow-up which indicates potential high risk 255
of poor outcomes. 256
Diabetes was identified as a risk factor for unsuccessful TB treatment in this study. 257
Previous studies have demonstrated that the correlation of diabetes with TB treatment failure 258
[12] could be attributed to altered drug absorption [13] and immune system as well as drug 259
interaction [14] . We further identified renal insufficiency/dialysis as a risk factor for TB-260 associated mortality. In patients undergoing dialysis, altered immune response associated 261 with uraemia and dialysis exacerbation have been identified as predisposing factors for 262 active TB development [15] . Patients with end-stage renal disease are more susceptible to 263 TB [16]. Furthermore, drug-induced hepatitis has been identified more frequently in patients 264 with TB and chronic renal failure than in those with TB but without chronic renal failure that 265 increase the risk of TB-associated mortality [17] . cohort study in Spain reported that elderly people were more likely to die from TB [19] . 270
A previous Dutch study (1993) (1994) (1995) (1996) (1997) showed an association between the risk of 271 treatment default and being in the high-risk group (asylum seekers, immigrants, illegal 272 immigrants, homeless individuals, prisoners and eastern European nationals) [6] . However, 273 the present study did not show that immigrants and asylum seekers as a high-risk group in 274 terms of outcomes (unsuccessful treatment and TB-associated mortality). It seems that 275 asylum seekers and immigrants received a successful treatment during the study period. high-risk group that requires longer and other treatment, and more study on their prognosis is 307
needed. 308
Several potential limitations need to be acknowledged. First, because we used data 309 from an administrative database, our dataset relied on reports from clinicians without any 310 direct observations by current investigators, which may have led to inaccuracies. Second, 311 several prominent predictors which may have further increased the discriminative value of 312 multivariate models, such as HIV, treatment delay duration, BCG vaccination history, 313 insurance coverage, education level, income and patient beliefs, could not be analysed due 314 to unavailability of data for a large number of patients. Third, a low mortality rate in this study 315 led to low precision of the associations between mortality outcome and some predictors, 316 such as age and initial TB location (CNS and miliary TB). However, we believe that the 317 systematic approach for data collection supported by information technology, national 318 guideline, control system for data collection and an integrated referral system for patients 319 with TB in the Netherlands led to a minimal bias in this study. Importantly, expanding the 320 national database coverage to include patients throughout the Netherlands will improve the 321 applicability of our results to the Dutch DSTB population. 322
In conclusion, although most DSTB cases included foreign-born patients, these 323 patients achieved similar TB treatment success compared with native-born patients. We 
